Skip to content

Upcoming and On-Demand Webinars

There are currently no upcoming webinars on our schedule. Please enjoy any of the webinars below on-demand:

On-Demand Webinars

2023 Webinars

TransCure & Xtalks Webinar: How Humanized Mouse Models Enforce Preclinical Studies in Immuno-Oncology

Presenters: Dan Georgess, PhD, Chief Scientific Officer, TransCure bioServices and
Eleonora Leucci, PhD, Professor at The Laboratory for RNA Cancer Biology, The Art of Discovery

Originally streamed on May 30th, 2023, in this webinar you will learn about:

  • An overview of the advantages of using humanized mouse models in immuno-oncology preclinical studies
  • Case studies demonstrating the advantages of using humanized mouse models for drug trials in immuno-oncology
  • RNA-based cancer-specific therapeutic strategy to overcome intrinsic resistance to immune checkpoint blockade

TransCure & Xtalks Webinar: How Humanized Mice Studies Can Accelerate Preclinical Research in Infectious Diseases

Presenters: Sebastien Tabruyn, PhD, Chief Scientific Officer, TransCure bioServices, and Iñigo Angulo-Barturen, PhD, CEO, The Art of Discovery

Originally streamed on April 25th, 2023, in this webinar you will learn about:

  • How the human immune system responds to infection in a Humanized CD34-NCG mouse model
  • The preclinical analysis toolkit of the HIV platform, and how the Humanized mouse model allows for the evaluation of drug candidates
  • The use of Humanized Plasmodium falciparum mouse models in the study of human malaria and the in vivo evaluation of new antimalarial drugs

TransCure & Xtalks Webinar: Why Use Humanized Mouse Models for Translational Studies in Inflammatory Disorders?

Presenters: Kiave-Yune Ho Wang Yin, PhD, Director of Innovation, TransCure bioServices and Natascha Wuillemin, Executive VP Immunology at Mabylon AG

Originally streamed on January 24th, 2023, in this webinar you will learn about:

  • Inflammatory bowel diseases, which include ulcerative colitis and Crohn’s disease, are characterized by a chronic inflammation of the intestinal tract
  • Peanut allergy affects up to two percent of the pediatric population and is a high unmet medical need as peanut ingestion is the most common cause of food induced anaphylaxis in the US

2022 Webinars

TransCure & Xtalks Webinar: How can Humanized Mouse Models be Used to Study Cancer & the Development of New Immune-Targeted Therapies?

Presenters: Sebastien Tabruyn, PhD, Chief Scientific Officer, TransCure bioServices, and Wout De Wispelaere, PhD Researcher, University of KU Leuven

Originally streamed on November 8th, 2022, in this webinar you will learn about:

  • The main characteristics of a full human immune system mouse model
  • How humanized mice allow the assessment of immune-checkpoint inhibitors, cell therapies, vaccines or antibodies
  • How to select the best tumor model for immunology and oncology research
  • A case study on an innovative solution to treat an aggressive tumor: uterine leiomyosarcomas (uLMS)

TransCure Webinar Series 2022: Infectious Diseases

Infectious Diseases: In this webinar, you will learn about humanized immune system mouse models and humanized liver mouse models for viral infections (HIV, HBV…)

  • Hu-mice to model HIV infection
  • Humanized liver mice to model HBV/HCV infections
  • Infection monitoring techniques
  • Drug candidates profiling: case studies
  • Q&A sessions with Dr. Tabruyn

TransCure Webinar Series 2022: Inflammatory Diseases

Inflammatory Disorders: In this webinar, you will learn about the translational predictability of humanized immune system mouse models for inflammation:

  • Hu-mice to model GI (gastro-intestinal) tract inflammation and lung fibrosis
  • IBD symptoms monitoring
  • Case studies: drug candidate profiling
  • Q&A sessions with Dr. Tabruyn

 

TransCure Webinar Series 2022: Immuno-Oncology

Immuno-Oncology: Best preclinical candidate selection using fully humanized immune system mouse models. In this webinar you will learn about:

  • A predictive fully humanized immune system mouse model
  • Select the most suitable cancer cell lines and/or PDX
  • The transient human cytokines boosting process
  • Several case studies will be presented in details
  • Q&A sessions with Dr. Tabruyn